The median concentration of biliary CEACAM6 in patients with benign disease was significantly lower than that of patients with cholangiocarcinoma (7.5 [3.0–22.0] vs. 40.0 [15.0–260.8] ng/ml; p = <.001). Here, CEACAM6 is linked to cholangiocarcinoma.